The NRG Oncology Podcast

This special Uterine Cancer Month episode includes three different perspectives in Uterine Cancer research. First we interview uterine and ovarian cancer survivor, NRG PAC Member, and Uterine Corpus Subcommittee Patient Advocate, Anna Wilson. Second we look at the recently activated NRG-GY035 clinical study with PI Dr. Amanda Fader. Lastly we discuss uterine cancer research within NRG with Gynecol...

In this episode, we discuss the results of the combined analysis of the prostate cancer studies RTOG 9202, 9413, 9902, and 0521 as well as learn more about translational science at NRG.

Our Podcast Co-Hosts interview NRG-GY018 study PI, Dr. Ramez Eskander on the reported mature results of the study in advanced or recurrent endometrial cancer at ASCO 2026.

The NRG Oncology Podcast discusses the American Society for Radiation Oncology’s (ASTRO) vision and goals, collaborations with cooperative groups such as NRG Oncology, and overcoming obstacles in radiation oncologywith ASTRO’s CEO, Dr. Vivek Kavadi. This is a special episode for ASTRO's 2026 Advocacy Day.

Our co-hosts interview Dr. Amanda Nickles Fader on the recently present results of NRG-GY019.

Our co-hosts discuss the NRG-BR009 'OFSET' study for premenopausal ER-positive/HER2-negative breast cancer patients that have a high risk of cancer returning with study team members Dr. Shannon Puhalla and Dr. Sandra Swain. Also on this episode, we interview Dr. Haane Massarotti on her own experience facing breast cancer as a young adult.

American Medical Association President, Dr. Bobby Mukkamala, discusses how his personal experiences in his cancer journey impact his outlook and goals in his AMA Presidency & Dr. James Yu discusses his experiences using patient-reported outcomes from clinical research to help guide health policy.

Our co-hosts interview NRG-HN009 PI Dr. Paul Harari on the recently reported initial results of NRG-HN009 at the 2026 Multidisciplary Head and Neck Cancer Symposium. Additionally, this episode discusses NRG-HN010 for HER2-expressing salivary gland cancer with Study PI, Dr. Alan Ho.

Our co-hosts discuss who the NRG Protocol Operations Management "POM" Committee is and what they are responsible for with outgoing Chair, Dr. Maria Werner-Wasik and incoming Chair, Dr. Alexandra Thomas.

In the first half of this episode, our co-hosts interview NRG Oncology Sarcoma Subcommittee Chairs, Dr. Dian Wang and Dr. William Tseng on the priorities and goals of the newer subcommittee within NRG's organization. In the second half, our co-hosts meet with MLB Player Chris Taylor and his wife Mary Taylor, the co-founders of the CT3 Foundation to discuss how sarcoma has touched their lives a...

JAMA Editor in Cheif, Dr. Kirsten Bibbins-Domingo discusses JAMA and the JAMA Network and the process for selection and publication of manuscripts.

We take a look at the barriers faced by smaller institutions and rural institutions with Dr. Naoto Ueno of the University of Hawaii in a two-episode series on small vs. larger institution challenges.

Today for Veteran's Day, we discuss the NRG Veteran Affairs and Military Treatment Facility Subcommittee and NCTN trials in the VA system with Subcommittee Chair, Dr. Vlad Sandulache.

For Pancreatic Cancer Awareness Month, we discuss the recently activated NRG-GI011 "LAP100" study for locally advanced pancreas cancer with study PI, Dr. Sanford.

Drs. Chun and Henke interview NRG NCORP PI, Dr. Deborah Bruner on the ins-and-outs of the NCI National Community Oncology Research Program (NCORP) as well as her trailblazing career thus far.

This episode, our co-hosts discuss the ASTRO late-breaking abstracts that were reported at the ASTRO 2025 annual meeting. Dr. Movsas discusses the quality of life results of NRG-LU005 and Dr. Mehta discusses the proton arm of NRG-BN001. Dr. Steven Frank takes a deeper look at proton implications through the NRG results that were presented at ASTRO. PLEASE NOTE: There is a correction to Dr. Movsas’...

NRG Oncology Podcast co-hosts sit with ASTRO President, Dr. Sameer Keole as well as ASTRO Plenary NRG research presenters, Dr. Shannon MacDonald (RadComp) and Dr. Rodney Ellis (NRG-GU005) to discuss results that were reported.

Our co-hosts discuss NRG-GU006 with Dr. Daniel Spratt. The results of NRG-GU006, a phase II clinical study in recurrent prostate cancer, were presented as a part of the 2025 American Society for Radiation Oncology (ASTRO) Annual Meeting Clinical Trials Session.

Our co-hosts sit with Dr. El-Deiry for his take on the current state of precision oncology, clinical research, and industry collaborations.

We interview Dr. Steven Waggoner on the NRG Oncology Ancillary Projects Committee (APC) and the conduct of ancillary projects.

We interview Dr. Erin Gillespie, PI of the NRG-CC014 "PREEMPT" study comparing radiation therapy to usual therapy for patients with high-risk bone metastases that are not causing pain.

We interview NRG Deputy Director of Membership and Research Integrity, Dr. David Miller, on the ins-and-outs of NRG Membership and the NRG Membership Committee.

We interview Dr. Jeff Bradley, the now Immediate Past Chair of the NRG Lung Cancer Committee regarding the past, present, and future of lung cancer in NRG as well as the importance of mentorship for our future research.

Dr. Ted Hong discusses the NRG-GI003 study comparing proton versus photons for hepatocellular carcinoma.

NRG Oncology Podcast Co-hosts sit with Dr. Edward Tanner, the Principal Investigator of the NRG-CC010 trial assessing the impact of sentinel lymph node mapping on patient-reported lower extremity limb dysfunction in endometrial cancer.